Owner: Just Charts URL:http://just-charts.blogspot.com/ Join Date: Sun, 26 Aug 2007 16:50:44 -0500 Rating:0 Site Description: Elliott Wave, StockPattern and Fibonacci StockCharts setups for investing & trading Site statistics:Click here
American Commercial Lines, ACLI 2007-10-09 09:00:33 There´s plenty of small tecnical issues in this transportation stock suggesting upside potential, unfortunately oscillators do not offer quick movement to the upside, but I bet it will come in near future. Stock kissing now with SMA50 line, I think stock makes bottom in here making oscillators turn slowly, but surely to the positive territory. Too many patterns exist that stock could have more room to the downside.Stock Charts Courtesy of www.WallStreetTape.com Read more:American
, Commercial
, Lines
Medarex, MEDX 2007-10-08 19:53:26 Stock Charts Courtesy of www.WallStreetTape.com
Steiner Leisure, STNR 2007-10-08 19:48:18 Steiner Leisure
has just cleared both, 50 and 200 SMA lines.Stock Charts Courtesy of www.WallStreetTape.com Read more:Steiner
China TechFaith (CNTF) 2007-10-17 20:45:11 One of the largest handset application software and handsetlution providers. Based in China
, the Company employs approximately 1,400 professionals, of whom 90% are engineers. TechFaith’s business includes handset design, feature phone solution, wireless module and data card, application software, and Smartphone and Pocket PC. With the capability of developing MMI / UI software on GSM/GPRS, CDMA1X, EVDO, WCDMA/UMTS, HSDPA and TD-SCDMA communication technologies, TechFaith is able to provide MMI/UI software packages that fulfill the specifications of handset brand owners and major global operators. TechFaith’s smartphone software is based on open operating systems including Linux and Windows Mobile.==============================================Perhaps we could have something big with elliott wave and fibonacci projections. Double or even triple Wedge with 2 different timezones, to consider, start identify a big picture, look at those fib retracements how stock has behaved at so far i
Isonics, ISON 2007-10-16 08:08:13 50 SMA break-out candidates with well open oscillators.Stock Charts Courtesy of www.WallStreetTape.com
Intermune, ITMN 2007-10-14 20:16:49 Extreme Chartpattern programming filling multiple requirements; Primary Fibonacci support bottom made at 61.8%, 50 days moving average break-out, bullish stockpattern (falling wedge) filled with elliott wave principals, extreme bullish oscilators and multiple timeframe crosses with stocastic, macd, rsi and cci. Also Extreme shortratio to cover, missing only fundamendals - well, who need them anyway ?If you sailed bear and short with this stock, I bet you have a serious troubles ahead. There´s over 6 million shares short, making days-to-cover ratio for 10 days and floated short is 18% of all available equity.
Qiao Xing, Xing 2007-10-18 21:54:27 Here´s another mobile stock from China, I think at least backtest possible for wedge upper line, even I have to confess this pattern is not so clear as another chinese one, but should be interesting to see these two future lookks alike.There´s major difference in technical view as this one is allready out of it´s wedge pattern. Unfortunately pretty big risk involved with this one also, you can draw that wedge upper line higher and if this would be a case then IV wave should be filled pretty much higher as well as wedge upper line meaning chart would miss wave V. Different is however, there´s smaller wedge inside the bigger one, which allready blow price upside.China USX index has now done even 8% daily movements, so the good news in volalitet is that these pattern should be pretty quickly solved and point direction, perhaps just in a few months time.Stock Charts Courtesy of www.WallStreetTape.com
Keryx Pharmaceuticals, KERX 2007-10-25 20:10:33 Keryx Biopharmaceuticals, Inc. is focused on the acquisition, development and commercialization of medically important, novel pharmaceutical products for the treatment of life-threatening diseases, including diabetes and cancer. Keryx's lead compound under development is Sulonex(TM), previously referred to as KRX-101, a first-in-class, oral heparinoid compound for the treatment of diabetic nephropathy, a life-threatening kidney disease caused by diabetes. Sulonex is in a pivotal Phase III and Phase IV clinical program under a Special Protocol Assessment with the Food & Drug Administration. Additionally, Keryx is developing Zerenex(TM), an oral, inorganic, iron-based compound that has the capacity to bind phosphate and form non-absorbable complexes. Zerenex is currently in Phase II clinical development for the treatment of hyperphosphatemia (elevated serum phosphorous levels) in patients with end- stage renal disease. Keryx is also developing clinical-stage oncology compounds, incl
Recommend Site To A Friend
